Company Overview
PLUS THERAPEUTICS, INC.
PSTVRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
5M
2025 FY
Net Income
-22M
2025 FY
Shares Outstanding
78M
2025 FY
EPS
-0.29USD
2025 FY
Company Information
SIC Code
3841
CIK Code
1095981
Exchange
Nasdaq
Location
US